New hope for rare blood cancers: international trial tests smart drug cocktails
Disease control
Recruiting now
This study tests new combinations of cancer drugs for people with MDS/MPN overlap syndromes, rare blood cancers. About 94 adults will receive an oral drug (ASTX727) plus another targeted medicine to see if the combination is safe and shrinks cancer. The goal is to control the dis…
Phase: PHASE1, PHASE2 • Sponsor: Michael Savona • Aim: Disease control
Last updated May 14, 2026 12:03 UTC